期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

自体造血干细胞移植治疗侵袭性淋巴瘤的新进展 被引量：3

The Advances in Treatment of Aggressive Lymphoma by Using Autologous Hematopoietic Stem Cell Transplantation
下载PDF
导出
摘要 目前相关业界同道内普遍认同，既往广泛使用多年的侵袭性淋巴瘤（aggressive lymphoma）的定义范畴．在最新的世界卫生组织（World Health Organization，WHO）2001年分类中，主要包括非霍奇金淋巴瘤（non-Hodgkin’s lymphoma，NHL）中的弥漫大B细胞淋巴瘤（diffuse large Bcell lymphoma，DLBCL）、套细胞淋巴瘤（mantle cell lymphoma，MCL）、外周T细胞淋巴瘤（peripheral T cell lymphoma，PTCL）及间变大T细胞淋巴瘤（anaplasticlargeTcelllymphoma，ATCL）等。
作者 张伯龙 马军
机构地区 哈尔滨血液病肿瘤研究所
出处 《循证医学》 CSCD 2008年第5期257-261,共5页 The Journal of Evidence-Based Medicine
关键词 自体造血干细胞移植 侵袭性淋巴瘤 autologous hematopoietic stem cell transplantation aggressive lymphoma
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献24

  • 1Kurnick NB, Montano A, Gerdes JC, et al. Preliminary observations on the treatment of postirradiation hematopoietic depression in man by the infusion of stored autologous bone marrow [J]. Ann Intern Med, 1958,49:973-986.
  • 2Appelbaum FR, Herzig GP, Ziegler JL, et al. Successful engraftment of cryopreserved autologous bone marrow in patient with malignant lymphoma [ J ]. Blood, 1978,52 : 85-95.
  • 3Apperley J, Carreras E, Gluekman E, et al. Haematopoietie stem cell transplantation (2008 revised edition) [M]. Forum Service Editore, Genoa, 2008.
  • 4张伯龙,高春纪.2006年有关自体造血干细胞移植治疗恶性肿瘤的新信息[M]//中国癌症基金会《中国肿瘤临床年鉴》编辑委员会主编.中国肿瘤临床年鉴.北京:中国协和医科大学出版社,2007:50-75.
  • 5Gulati SC, Shank B, Black P, et al. Autologous bone marrow transplantation for patients with poor-prognosis lymphoma [J]. J Clin Oncol, 1988,6: 1303-1313.
  • 6Haioun C, Lepage E, Gisselbrecht C, et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non- Hodgkin lymphoma in first complete remission: A study of 464 patients. Groupe d'Etude des Lymphomes de l'Aduhe [J]. J Clin Oneol, 1994,12:2543-2551.
  • 7Verdonck LF, van Putten WL, Hagenbeek A, et al. Comparison of CHOP chemotherapy with autologous bone marrow transplantalion for slowly responding patients with aggressive non-Hodgkin's lymphoma [J]. N Engl J Med, 1995, 332: 1045-1051.
  • 8Haioun C,Lepage E, Gisselbreeht C, et al. Benifit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. Groupe d'Etude des lymphomes de l'Adulte [J]. J Clin Oncol, 1997,15:1131- 1137.
  • 9Gianni AM, Bregni M, Siena S, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma [J]. N Engl J Med, 1997,536 : 1290-1297.
  • 10Reyes F, Lepage E, Morel P, et al. Failure of first line inductive high-dose chemotherapy in poor risk patients with aggressive lymphoma: Updated results of the randomized LNH93-3 study [J]. Blood, 1997,90:594(suppl 1,abstr 2640).

同被引文献29

  • 1张东华,张路,肖毅,黄伟,李登举,冉丹,黄亮,周剑锋,黄梅,孙汉英,刘文励.Clinical Observation of Patients with Hematologic Malignancies Treated with Hematopoietic Stem Cell Transplantation[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2004,24(4):345-349. 被引量：5
  • 2杨璐,刘卓刚.自体造血干细胞移植体外净化的研究进展[J].国外医学（儿科学分册）,2005,32(6):369-371. 被引量：2
  • 3Seki H, Ohshima, Fujisaki T, et al. Prognostic impact of immuno-histo- chemical biomarkers in diffuse large B-cell lymphoma in theRituximab era . Cancer Sci ,2009 ,100( 10) : 1842-1847.
  • 4Van Imhoff GW,van der Holt B,Mackenzie MA, et al. Impact ofthree courses of intensified CHOP prior to high-dose sequentialtherapy followed by autologous stem-cell transplantation as first-linetreatment in poor-risk, aggressive non- hodgkin^s lymphoma : com-parative analysis of Dutch-Belgian Hemato- Oncology CooperativeGroup Studies 27 and 40. J Clin Oncol,2005,23 ( 16): 3793-3801.
  • 5Haioun C, Mounier N, Quesnel B, et al. Tandem autotransplantas first-line consolidative treatment in poor-risk aggressive lympho-ma: a pilot study of 36 patients. Ann Oncol,2001,12( 12) : 1749-1755.
  • 6Feugier P, van H, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse LargeB-cell lymphoma : A study by the groupe dEtude des lymphoma del'Adulte . J Clin Oncol, 2005,18 (23) :41174126.
  • 7Greb A, Bohlius J, Trelle S, et al. High-dose chemotherapywithautologous stem cell support in first-line treatment of aggressivenon-Hodgkin lymphoma-results of a comprehensive meta-analysis .non-Hodgkin lymphoma-results of a comprehensive meta-analysis. Cancer Treat Rev, 2007, 33(4): 338-346.
  • 8Tarella C, Zanni M, Di Nicola M, et al. Prolonged survival inpoor-risk diffuse large B-cell lymphoma following front-line treat-ment with rituximab-supplemented,early-intensified chemotherapywith multiple autologous hematopoietic stem cell support : a multi-center study by GITIL ( Gruppo Italiano Terapie Innovative neiLinfomi). Leukemia,2007,21(8): 1802-1811.
  • 9Vranovsky A, Ladicka M, Lakota J. Autologous stem cell trans-plantation in first-line treatment of high-risk aggressive non-Hodgkin ,s lymphoma. Neoplasma ,2008,55 (2) :107-112.
  • 10Papajik T, Raida L, Faber E. High-dose therapy and autologousstem cell transplantation in patients with diffuse large B-cell lym-phoma in first complete or partial remission. Neoplasma, 2008,55(3):215-221.

引证文献3

二级引证文献7

循证医学
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部